Riskpilot← Back to searchSign inGet full accessAH BIOTEC ApS
APSIn liquidationCVR 27986137Gammel Viborgvej 11AWholesale of pharmaceutical and medical goods · NACE 4646Est. 2004— employees
Revenue 2022
DKK -6K
EBITDA margin
100.0%
+28% vs 2021
Equity ratio
84.1%
Financial strength
Net profit 2022
DKK -5K
+25% vs 2021
| Revenue | DKK -6K | — |
| EBITDA | DKK -6K | +28% |
| Net profit | DKK -5K | +25% |
| Total assets | DKK 35K | -17% |
| Equity | DKK 29K | -15% |
| Employees | — | — |
Legal name
AH BIOTEC ApS
CVR number
27986137
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. august 2004
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Gammel Viborgvej 11A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -9 | -13 | -10 | — | -11 | -11 | -11 | -11 | -12 | — | -5 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -9 | -13 | -10 | -13 | -11 | -11 | -11 | -11 | -12 | -8 | -5 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -9 | -13 | -10 | -13 | -11 | -11 | -11 | -11 | -12 | -8 | -5 |
| Net financials | -0 | -1 | 6 | 3 | 2 | 2 | -1 | -1 | -1 | -1 | -1 |
| Profit before tax | -10 | -14 | -4 | -10 | -8 | -9 | -12 | -13 | -13 | -9 | -7 |
| Tax | 2 | -3 | -1 | -2 | -2 | -2 | -3 | -3 | -3 | -2 | -1 |
| Net profit | -11 | -10 | -3 | -8 | -6 | -7 | -10 | -10 | -10 | -7 | -5 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 179 | 168 | 162 | 157 | 153 | 92 | 72 | 63 | 53 | 42 | 35 |
| Equity | 105 | 95 | 92 | 84 | 78 | 71 | 61 | 51 | 41 | 34 | 29 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 74 | 73 | 71 | 73 | 75 | 21 | 11 | 12 | 12 | 8 | 6 |
| Total debt | 74 | 73 | 71 | 73 | 75 | 21 | 11 | 12 | 12 | 8 | 6 |
EBITDA margin
-550000.0%
This company
15.8%
Market median
-3481113% vs market
20122022
Equity ratio
84.1%
This company
38.2%
Market median
+120% vs market
20122022
Return on equity
-17.8%
This company
18.4%
Market median
-197% vs market
20122022
Net profit margin
-519100.0%
This company
8.1%
Market median
-6408742% vs market
20122022
Asset turnover
-0.16×
This company
1.12×
Market median
-114% vs market
20122022
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20122022
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HV Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
BB Unofficial title | Unofficial title | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2004 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
AH DIAGNOSTICS A/S | Company | 100.0% | 100.0% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AH BIOTEC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helle Vibeke Zacho | Chief Executive Officer | 0 companies |
| Brian Bjørnholdt | Unofficial title | 0 companies |
| Jørgen Lægaard | Chairman | 0 companies |
| Niels Stampe Rüdiger | Chairman | 0 companies |
| Jørn Kildegaard Andersen | Board of Directors | 0 companies |
| Asger Bach-Larsen | Board of Directors | 0 companies |
| Mogens Birkebæk | Board of Directors | 0 companies |
| Kurt Sigurd Toft | Board of Directors | 0 companies |
| Helle Sørensen | Board of Directors | 0 companies |